The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity
- 28 February 1997
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 128 (2) , 183-190
- https://doi.org/10.1016/s0021-9150(96)05985-0
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Lipoprotein Lipase Hin dIII Polymorphism Modulates Plasma Triglyceride Levels in Visceral ObesityArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Variability of plasma apolipoprotein (apo) A-II levels associated with an apo A-II gene polymorphism in monozygotic twin pairsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- The MspI restriction fragment length polymorphism 3′ to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery diseaseAtherosclerosis, 1992
- Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- High-density lipoprotein cholesterol levels as a marker of reverse cholesterol transportThe American Journal of Cardiology, 1989
- Plasma lipoprotein lipids in relation to the MspI polymorphism of the apolipoprotein All gene in Caucasian men Lack of association with plasma triglyceride concentrationAtherosclerosis, 1989
- Stimulation of lecithin: cholesterol acyltransferase activity by apolipoprotein A‐II in the presence of apolipoprotein A‐IEuropean Journal of Biochemistry, 1986
- Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérumClinica Chimica Acta; International Journal of Clinical Chemistry, 1960
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955
- THE VOLUME OF THE LUNG DETERMINED BY HELIUM DILUTION. DESCRIPTION OF THE METHOD AND COMPARISON WITH OTHER PROCEDURESJournal of Clinical Investigation, 1949